Precision BioSciences, Inc (DTIL) Stock Price

6.50 ▲ +0.65 (+11.11%)
Open: 5.91 Vol: 275.27K Day's range: 5.87 - 6.60 Oct 15, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
DTIL Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 6.46▼ 6.33▲ 6.28▲ 5.88▲ 5.48▲
MA10 6.44▲ 6.19▲ 6.08▲ 5.73▲ 5.17▲
MA20 6.26▲ 5.99▲ 5.84▲ 5.40▲ 4.93▲
MA50 5.93▲ 5.80▲ 5.76▲ 5.05▲ 5.23▲
MA100 5.78▲ 5.70▲ 5.52▲ 4.90▲ 8.05▼
MA200 5.73▲ 5.38▲ 5.20▲ 4.97▲ 29.14▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.005▲ 0.052▲ 0.083▲ 0.079▲ 0.225▲
RSI 70.144▲ 77.735▲ 74.393▲ 74.083▲ 63.892▲
STOCH 75.237     90.829▲ 95.861▲ 77.685     73.898    
WILL %R -20.430▲ -13.287▲ -8.085▲ -5.988▲ -4.219▲
CCI 63.939     154.428▲ 140.530▲ 219.601▲ 247.161▲
Latest Filters Detected On DTIL
▲ RSI $DTIL RSI(14) Crossed Above 70 Set Alert
▲ BREAK $DTIL Price Breaks 60 Days High Set Alert
▲ BREAK $DTIL Price Breaks 30 Days High Set Alert
▲ BREAK $DTIL Price Breaks 20 Days High Set Alert
▲ BREAK $DTIL Price Breaks 10 Days High Set Alert
Precision BioSciences, Inc News
Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting® 2025
Tuesday, October 14, 2025 04:15 AM
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
Precision BioSciences Announces Publication in Nucleic Acids Research Elucidating the Mechanisms for High Efficiency Gene Insertion in Dividing and Non-Dividing Cells Using ...
Thursday, October 09, 2025 04:12 AM
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
Precision BioSciences Announces Opening of First Clinical Trial Site in U.S. for ELIMINATE-B Trial
Tuesday, October 07, 2025 04:15 AM
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
DTIL historical stock data
date open high low close volume
15/10/25 5.91 6.60 5.87 6.50 275,268
14/10/25 5.52 5.9817 5.25 5.85 98,554
13/10/25 5.67 5.70 5.54 5.56 66,873
10/10/25 5.88 5.9399 5.54 5.62 84,876
09/10/25 5.80 5.89 5.70 5.88 85,350
08/10/25 5.70 5.7829 5.59 5.70 51,683
07/10/25 5.77 5.80 5.581 5.68 67,213
06/10/25 5.44 5.7683 5.3964 5.67 144,858
03/10/25 5.44 5.45 5.3645 5.44 85,956
02/10/25 5.40 5.45 5.26 5.42 54,507
Quote Details
52wk Low:3.61
52wk High:9.20
Vol:275.27K
Avg Vol(3m):1.6M
1Y Chng:-19.45%
1M Chng:+29.22%
Add to Watch List
More Information
Index US Composite
Market Cap. 68.95M